Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 15/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TDO2 | P48775 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7210861 | 0.82 | PTGS2 (0.71) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7216743 | 0.81 | PTGS2 (0.74) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7212097 | 0.80 | PTGS2 (1.00) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7216668 | 0.78 | PTGS2 (0.59) | PTGS2PTGS1IDO1CYP2C9TDO2 | |
| SCHEMBL3831175 | 0.77 | PTGS2 (1.00) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL5309102 | 0.75 | PTGS2 (1.00) | PTGS2PTGS1 | |
| SCHEMBL7215254 | 0.75 | PTGS2 (0.78) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7210644 | 0.75 | PTGS2 (0.78) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL6517559 | 0.75 | PTGS2 (0.89) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL6513769 | 0.75 | PTGS2 (0.78) | PTGS2KDM4EALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1369415-A1 | Substituted pyrrolyl compounds for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2003-12-10 | — | — | EP | claimed |
| EP-0946507-A1 | SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1999-10-06 | — | — | EP | claimed |
| WO-1998025896-A1 | SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1998-06-18 | — | — | WO | claimed |
| EP-1369415-A1 | Substituted pyrrolyl compounds for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2003-12-10 | — | — | EP | disclosed |
| US-5935990-A | PYRROLYL DERIVATIVES HAVING AT POSITION 1 OR 5 A PHENYL SUBSTITUTED WITH METHYLSULFONYL OR AMINOSULFONYL; INHIBIT CYCLOOXYGENASE-2 FOR USE TREATMENT OF INFLAMMATION, AS AN ANALGESIC, OR AS AN ANTIPYRETIC | G.D. SEARLE & CO. (US) | 1999-08-10 | — | — | US | disclosed |